The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis

References

1. ↵
   1. Bousser MG,
   2. Crassard I

   (2012) Cerebral venous thrombosis, pregnancy and oral contraceptives. Thromb Res 130, Suppl 1, S19–S22.
2. ↵
   1. Ruiz-Sandoval JL,
   2. Chiquete E,
   3. Bañuelos-Becerra LJ,
   4. Torres-Anguiano C,
   5. González-Padilla C,
   6. Arauz A,
   7. et al.

   (2012) Cerebral venous thrombosis in a Mexican multicenter registry of acute cerebrovascular disease: the RENAMEVASC study. J Stroke Cerebrovasc Dis 21, 395–400.
3. ↵
   1. Piazza G

   (2012) Cerebral venous thrombosis. Circulation 125, 1704–1709.
4. ↵
   1. Saposnik G,
   2. Barinagarrementeria F,
   3. Brown RD Jr.,
   4. Bushnell CD,
   5. Cucchiara B,
   6. Cushman M,
   7. et al.

   (2011) Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 1158–1192.
5. ↵
   1. Einhäupl K,
   2. Stam J,
   3. Bousser MG,
   4. De Bruijn SF,
   5. Ferro JM,
   6. Martinelli I,
   7. et al.

   (2010) EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 17, 1229–1235.
6. ↵
   1. Coutinho J,
   2. de Bruijn SF,
   3. Deveber G,
   4. Stam J

   (2011) Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev 8, CD002005.
7. ↵
   1. Alvis-Miranda HR,
   2. Milena Castellar-Leones S,
   3. Alcala-Cerra G,
   4. Rafael Moscote-Salazar L

   (2013) Cerebral sinus venous thrombosis. J Neurosci Rural Pract 4, 427–438.
8. ↵
   1. Coutinho JM,
   2. Ferro JM,
   3. Canhao P,
   4. Barinagarrementeria F,
   5. Bousser MG,
   6. Stam J

   (2010) Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke 41, 2575–2580.
9. ↵
   1. Garcia DA,
   2. Baglin TP,
   3. Weitz JI,
   4. Samama MM

   (2012) Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141, e24S–e43S.
10. ↵
    1. Erkens PMG,
    2. Prins MH

    (2010) Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 9, CD001100.
11. ↵
    1. Fleet J,
    2. Birns J,
    3. Bhalla A

    (2014) Cerebral Venous Thrombosis in Adults. J Neurol Disord Stroke 2, 1033.
12. ↵
    1. Berthier E,
    2. Decavel P,
    3. Vuillier F,
    4. Verlut C,
    5. Moulin T,
    6. de Bustos Medeiros E

    (2013) Reliability of NIHSS by telemedicine in non-neurologists. Int J Stroke 8, E11.
13. ↵
    1. Quinn TJ,
    2. Dawson J,
    3. Walters MR,
    4. Lees KR

    (2009) Reliability of the modified Rankin Scale: a systematic review. Stroke 40, 3393–3395.
14. ↵
    1. Miller DJ,
    2. Simpson JR,
    3. Silver B

    (2011) Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies. Neurohospitalist 1, 138–147.
15. ↵
    1. Misra UK,
    2. Kalita J,
    3. Chandra S,
    4. Kumar B,
    5. Bansal V

    (2012) Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial. Eur J Neurol 19, 1030–1036.